The relationship of serum uric acid with non-alcoholic fatty liver disease

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 383-388

  Sertoglu, Erdim ^a   Ercin, Cemal Nuri ^b   Celebi, Gurkan ^b   Gurel, Hasan ^b   Kayadibi, Huseyin ^c   Genc, Halil ^d   Kara, Muammer ^e   Dogru, Teoman ^b  

^a ANKARA MEVKI MILITARY HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c Adana Children Hospital   (Turkey)

^d Izmir Military Hospital   (Turkey)

^e Etimesgut Military Hospital Eye Clinic   (Turkey)

Author keywords

Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; DIABETIC PATIENT; FATTY LIVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERURICEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIMPLE STEATOSIS; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADULT; ANTHROPOMETRY; HUMANS; HYPERURICEMIA; MALE; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; URIC ACID;

EID: 84897115460     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.01.029     Document Type: Article

References (40)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
2. Anstee Q.M., Targher G., Day C.P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013, 10:330-344.
3. Adams L.A., Lymp J.F., St Sauver J., Sanderson S.O., Lindor K.D., Feldstein A., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
4. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410.
5. Maxwell S.R.J., Thomason H., Sandler D., Leguen C., Baxter M.A., Thorpe G.H.G., et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997, 27:484-490.
6. Proctor P.H. Uric acid: neuroprotective or neurotoxic?. Stroke 2008, 39:e88.
7. Bos M.J., Koudstaal P.J., Hofman A., Witteman J.C., Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:1503-1507.
8. Dehghan A., van Hoek M., Sijbrands E.J., Hofman A., Witteman J.C. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 31:361-362.
9. Sui X., Church T.S., Meriwether R.A., Lobelo F., Blair S.N. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008, 57:845-852.
10. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
11. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
12. Lonardo A., Loria P., Leonardi F., Borsatti A., Neri P., Pulvirenti M., et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 2002, 34:204-211.
13. Lee Y.J., Lee H.R., Lee J.H., Shin Y.H., Shim J.Y. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med 2010, 48:175-180.
14. Li Y., Xu C., Yu C., Xu L., Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009, 50:1029-1034.
15. Lee K. Relationship between uric acid and hepatic steatosis among Koreans. Diabetes Metab 2009, 35:447-451.
16. Xu C., Yu C., Xu L., Miao M., Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One 2010, 5:e11578.
17. Lee J.W., Cho Y.K., Ryan M., Kim H., Lee S.W., Chang E., et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 2010, 4:378-383.
18. Lee S., Jin Kim Y., Yong Jeon T., Hoi Kim H., Woo Oh S., Park Y., et al. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study. Scand J Gastroenterol 2006, 41:566-572.
19. Kurata A., Shigematsu Y., Higaki J. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res 2005, 28:133-139.
20. Baba T., Amasaki Y., Soda M., Hida A., Imaizumi M., Ichimaru S., et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res 2007, 30:823-829.
21. Colloredo G., Guido M., Sonzogni A., Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003, 39:239-244.
22. Petta S., Cammà C., Cabibi D., Di Marco V., Craxì A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011, 34:757-766.
23. Bugianesi E., Marchesini G. Uric acid levels and liver fibrosis in nonalcoholic fatty liver disease. Hepatology 2004, 39:1749.
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
25. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., Turner R. Homeostasis model assessment: insulin resistance and beta cell function from fasting glucose and insulin concentration in man. Diabetologia 1985, 28:412-419.
26. NCEP Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 5:2486-2497.
27. Website: American Diabetes Association Recommendations Available at, [Accessed: 5 Nov 2013]. http://www.amc.edu/pathology_labservices/addenda/addenda_documents/Americandiabetesassociationrecommendations2.pdf.
28. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 411:313-321.
29. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004, 53:2087-2094.
30. Website: World Health Organization Available at, [Accessed: 4 Nov 2013]. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
31. Li C., Hsieh M.C., Chang S.J. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 2013, 25:210-216.
32. Yoo T.W., Sung K.C., Shin H.S., Kim B.J., Kim B.S., Kang J.H., et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005, 69:928-933.
33. Federico A., Trappoliere M., Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Dig Liver Dis 2006, 38:789-801.
34. Cohen E., Krause I., Fraser A., Goldberg E., Garty M. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Isr Med Assoc J 2012, 14:676-680.
35. Hwang I.C., Suh S.Y., Suh A.R., Ahn H.Y. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci 2011, 26:386-391.
36. Sirota J.C., McFann K., Targher G., Johnson R.J., Chonchol M., Jalal D.I. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 2013, 62:392-399.
37. Lonardo A., Loria P., Leonardi F., Borsatti A., Neri P., Pulvirenti M., et al. Policentrica Steatosi Epatica Non Alcolica. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 2002, 34:204-211.
38. Dogru T., Genc H., Tapan S., Bagci S. Hyperuricemia in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011, 34:1042-1043.
39. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
40. Vos M.B., Colvin R., Belt P., Molleston J.P., Murray K.F., Rosenthal P., et al. NASH CRN Research Group. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012, 54:90-96.